Anita Modi is rewriting the rules of drug development. As CEO & Co-Founder of Peer AI, she's deploying specialized AI agents that cut regulatory documentation workflows from 55-94% -- accelerating the path from discovery to patients. With roots in Computational Biology at Princeton, a Harvard MBA, and a track record spanning a $1B+ IPO and a biotech acquisition, Anita brings rare depth to one of healthcare's most complex challenges. Her work isn't just about efficiency. It's about getting life-saving therapies to the people who need them, faster.